Phenom 27 Catheter
Cathera
Product: Solitaire X-PACK — all models and sizes
FDA Clearance Information
The Phenom 27 Catheter received FDA clearance through the 510(k) pathway on June 11, 2018. It is manufactured by Cathera and classified as a Class 2 medical device.
What It Is
FDA-Cleared Indications
- Percutaneous catheter use within the cardiovascular system, consistent with FDA product code DQY and 21 CFR 870.1250.
- The supplied FDA summary does not state a complete disease-specific or procedure-specific indication.
Clinical Applications
- Use as a percutaneous catheter during procedures that match the device's current FDA-cleared labeling.
- Use in catheter-based vascular procedures when the catheter's labeled size, compatibility, and intended anatomy are appropriate.
Reported off-label uses
- Use as a distal access catheter for neurointerventional procedures, including navigation toward intracranial aneurysms, has been described for this device type but should not be assumed to be FDA-cleared without reviewing the current labeling.
- Use to support delivery of neurovascular implants such as flow-diverter devices has been described in clinical practice; this is not confirmed as an FDA-cleared indication by the information supplied.
Off-label use: these uses are reported in practice or the literature but are not part of the FDA-cleared indications. Physicians may use a cleared device off-label based on their medical judgment; the manufacturer may not promote off-label uses.
Evidence Summary
Reported Outcomes
Safety Profile
Evidence Limitations
Practical Considerations
- Confirm the current Instructions for Use before selecting the catheter; the supplied record does not include the catheter's dimensions, working length, inner diameter, outer diameter, or compatible guidewire and delivery-system specifications.
- Verify compatibility with the intended access sheath, guide catheter, guidewire, contrast medium, and any implant or treatment system.
- Use fluoroscopic or other appropriate imaging guidance and follow institutional protocols for catheter advancement, flushing, and handling.
- MRI safety information is not provided in the supplied FDA record. Check the current labeling for MR Safe, MR Conditional, or MR Unsafe status before MRI.
- Potential risks are those associated with percutaneous catheterization and the treated vascular system, including vascular injury, bleeding, thrombosis, embolization, infection, contrast reaction, and ischemic complications.
Procedures that use this device
Frequently Asked Questions
What are the clinical indications for Phenom 27 Catheter?
The Phenom 27 Catheter is indicated for use in neurointerventional procedures, particularly for the placement of flow diverters in cerebral aneurysms.
What outcomes have been reported in clinical studies?
Studies report successful navigation and placement of flow diverters with reduced procedure time and fewer access-site complications using the Phenom 27 Catheter.
What complications have been reported?
Reported complications include challenges in navigating complex vascular anatomy, though specific adverse events were not detailed in the studies.